BRIEF published on 07/02/2024 at 15:06, 2 years 3 months ago Newswire Ranked #1 in Press Release Distribution According to G2’s Summer 2024 Grid Report Newswire Press Release Distribution Media Monitoring G2 Report AI Writing Assistant
BRIEF published on 07/02/2024 at 15:06, 2 years 3 months ago Newswire classé n°1 en matière de distribution de communiqués de presse selon le rapport de grille de l'été 2024 de G2 Distribution Des Communiqués De Presse Fil De Presse Rapport G2 Surveillance Des Médias Assistant D'écriture IA
BRIEF published on 07/02/2024 at 15:05, 2 years 3 months ago Monthly Information on Voting Rights and Shares – June 2024 Voting Rights Icade Shares Euronext Financial Disclosure
BRIEF published on 07/02/2024 at 15:05, 2 years 3 months ago Information mensuelle sur les droits de vote et les actions – juin 2024 Icade Euronext Actions Droit De Vote Divulgation Financière
BRIEF published on 07/02/2024 at 15:05, 2 years 3 months ago ICADE : Information Mensuelle sur le Capital et les Droits de Vote Capital Droits De Vote Icade Actions
BRIEF published on 07/02/2024 at 15:05, 2 years 3 months ago ICADE: Monthly Information on Capital and Voting Rights Voting Rights Capital Icade Actions
BRIEF published on 07/02/2024 at 15:05, 2 years 3 months ago Vox Royalty Corp. Announce Updates for Plutonic East, Bulong, and Koolyanobbing Projects Gold Production Vox Royalty Bulong Plutonic East Koolyanobbing
BRIEF published on 07/02/2024 at 15:05, 2 years 3 months ago Vox Royalty Corp. annonce des mises à jour pour les projets Plutonic East, Bulong et Koolyanobbing Production D'or Vox Royauté Bulong Koolyanobbing Est Plutonique
BRIEF published on 07/02/2024 at 15:05, 2 years 3 months ago GB Sciences Signs Licensing Deal with Endopure Life Sciences for Cannabinoid-Based Neurological Treatments Neurological Disorders GB Sciences Endopure Life Sciences Cannabinoid-based Treatments Licensing Deal
BRIEF published on 07/02/2024 at 15:05, 2 years 3 months ago GB Sciences signe un accord de licence avec Endopure Life Sciences pour des traitements neurologiques à base de cannabinoïdes Troubles Neurologiques Accord De Licence GB Sciences Sciences De La Vie Endopure Traitements À Base De Cannabinoïdes
Published on 10/15/2026 at 13:05, 16 minutes ago Impauer Technologies Announces Commercial Launch of Pauerone Wallet V1 Across Android, Web, And Browser Extension
Published on 10/15/2026 at 13:00, 21 minutes ago BULGOLD Defines the 2.2km-Long BL Vein Corridor at the Lutila Gold Project
Published on 10/15/2026 at 13:00, 21 minutes ago Nepra Foods Appoints Kim Mayo Chief Operating Officer
Published on 10/15/2026 at 13:00, 21 minutes ago CoTec and Battery Mineral Resources Enter Strategic Partnership to Unlock Additional Copper Production and Growth Opportunities at Punitaqui
Published on 10/15/2026 at 13:05, 16 minutes ago The Next Evolution of ASKB: Your Insights, Bloomberg's Intelligence, One Conversation
Published on 10/15/2026 at 12:47, 34 minutes ago Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program XS3202009547
Published on 10/15/2026 at 12:43, 38 minutes ago Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program XS3195123065
Published on 10/15/2026 at 12:40, 41 minutes ago Turkiye Garanti Bankasi A.S.: Board of Directors Resolution Regarding the Issuance of Asset-Backed Securities
Published on 10/15/2026 at 12:37, 44 minutes ago Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program XS3200020363
Published on 10/15/2026 at 07:27, 5 hours 54 minutes ago Saint-Gobain strengthens its infrastructure offer in North America with the acquisition of D.S. Brown in construction chemicals
Published on 10/15/2026 at 07:27, 5 hours 54 minutes ago Saint-Gobain renforce son offre pour le marché des infrastructures en Amérique du Nord avec l’acquisition de D.S. Brown dans la chimie de la construction
Published on 10/14/2026 at 18:00, 19 hours 21 minutes ago CIS : Chiffre d’affaires du 3ème trimestre 2026 supérieur aux attentes : accélération de la croissance et visibilité renforcée.
Published on 10/14/2026 at 18:00, 19 hours 21 minutes ago CIS : Q3 2026 revenue higher than expected: accelerated growth and increased visibility.
